Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells

NeuroReport

Volumn 23, Issue 17, 2012, Pages 989-994

  Peritore, Carina S ^a   Ho, Angela ^b   Yamamoto, Bryan K ^c   Schaus, Scott E ^a  

^a BOSTON UNIVERSITY   (United States)

^b Boston University   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

bioflavonoids; hydrogen peroxide; L DOPA; peroxyfluor 1; resveratrol

Indexed keywords

EPIGALLOCATECHIN GALLATE; HYDROGEN PEROXIDE; LEVODOPA; QUERCETIN; RESVERATROL;

ARTICLE; CELL VIABILITY; DRUG EFFECT; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTIOXIDANTS; CATECHIN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; FIBROBLASTS; FLUORESCEINS; HUMANS; HYDROGEN PEROXIDE; LEVODOPA; MONOAMINE OXIDASE; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; QUERCETIN; STILBENES; TYROSINE; TYROSINE 3-MONOOXYGENASE;

EID: 84869476185     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32835a4ea4     Document Type: Article

References (25)

1. Martin A, Youdim K, Szprengiel A, Shukitt-Hale B, Joseph J. Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. Nutr Rev 2002; 60:308-326.
2. Beal MF, Shults CW. Effects of coenzyme Q10 in Huntington's disease and early Parkinson's disease. Biofactors 2003; 18:153-161.
3. Fenton H. Oxidation of tartaric acid in the presence of iron. J Chem Soc Trans 1894; 65:899-910.
4. Fridovich I. The biology of oxygen radicals. Science 1978; 201:875-880.
5. Serbinova E, Choo M, Packer L. Distribution and antioxidant activity of a palm oil carotene fraction in rats. Biochem Int 1992; 28: 881-886.
6. Schroeder EK, Kelsey NA, Doyle J, Breed E, Bouchard RJ, Loucks FA, et al. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal 2009; 11:469-480.
7. Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 2009; 11:2851-2897.
8. Lipski J, Nistico R, Berretta N, Guatteo E, Bernardi G, Mercuri NB. L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease? Prog Neurobiol 2011; 94:389-407.
9. Lovenberg W, Weissbach H, Udenfriend S. Aromatic L-amino acid decarboxylase. J Biol Chem 1962; 237:89-93.
10. Graham DG. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978; 14: 633-643.
11. Kopin IJ. Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 1985; 37:333-364.
12. Graham DG, Tiffany SM, Bell WR Jr., Gutknecht WF. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 1978; 14:644-653.
13. Chang MC, Pralle A, Isacoff EY, Chang CJ. A selective, cell-permeable optical probe for hydrogen peroxide in living cells. J Am Chem Soc 2004; 126:15392-15393.
14. Helson L, Biedler JL. Catecholamines in neuroblastoma cells from human bone marrow, tissue culture, and murine C-1300 tumor. Cancer 1973; 31:1087-1091.
15. Breier JM, Bankson MG, Yamamoto BK. L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions. J Neurosci 2006; 26:290-299.
16. Kelsey NA, Wilkins HM, Linseman DA. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010; 15:7792-7814.
17. Pedrosa R, Soares-da-Silva P. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br J Pharmacol 2002; 137:1305-1313.
18. Lai CT, Yu PH. Dopamine-and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol 1997; 53:363-372.
19. Basma AN, Morris EJ, Nicklas WJ, Geller HM. L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J Neurochem 1995; 64:825-832.
20. Smith TS, Parker WD Jr, Bennett JP Jr. L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity? NeuroReport 1994; 5:1009-1011.
21. Mytilineou C, Han SK, Cohen G. Toxic and protective effects of L-dopa on mesencephalic cell cultures. J Neurochem 1993; 61:1470-1478.
22. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978; 38:3751-3757.
23. Jain P, Cerone MA, LeBlanc AC, Autexier C. Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons. J Neurosci Res 2007; 85:83-89.
24. Hashimoto W, Kitayama S, Kumagai K, Morioka N, Morita K, Dohi T. Transport of dopamine and levodopa and their interaction in COS-7 cells heterologously expressing monoamine neurotransmitter transporters and in monoaminergic cell lines PC12 and SK-N-SH. Life Sci 2005; 76:1603-1612.
25. Spencer JP, Kuhnle GG,Williams RJ, Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 2003; 372:173-181.